High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.

Abstract

OBJECTIVE YKL-40 is an inflammation-associated glycoprotein supposed to have a role in cell survival and angiogenesis. Renal cell carcinoma (RCC) is characterized by varying prognosis and risk of relapse after a disease-free period of years. Prognostic markers are critically needed. This study investigated whether YKL-40 could be a useful biomarker in RCC… (More)
DOI: 10.1080/21681805.2017.1327885

Topics

6 Figures and Tables

Slides referencing similar topics